{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T07:29:40Z","timestamp":1791444580682,"version":"4.3.3"},"reference-count":233,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2021,10,23]],"date-time":"2021-10-23T00:00:00Z","timestamp":1634947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Government contract of the Institute of Immunology and Physiology","award":["\u0410\u0410\u0410\u0410-\u041021-121012090091-6"],"award-info":[{"award-number":["\u0410\u0410\u0410\u0410-\u041021-121012090091-6"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Chronic kidney disease can progress to end-stage chronic renal disease (ESRD), which requires the use of replacement therapy (dialysis or kidney transplant) in life-threatening conditions. In ESRD, irreversible changes in the kidneys are associated with systemic changes of proinflammatory nature and dysfunctions of internal organs, skeletal muscles, and integumentary tissues. The common components of ESRD pathogenesis, regardless of the initial nosology, are (1) local (in the kidneys) and systemic chronic low-grade inflammation (ChLGI) as a risk factor for diabetic kidney disease and its progression to ESRD, (2) inflammation of the classical type characteristic of primary and secondary autoimmune glomerulonephritis and infectious recurrent pyelonephritis, as well as immune reactions in kidney allograft rejection, and (3) chronic systemic inflammation (ChSI), pathogenetically characterized by latent microcirculatory disorders and manifestations of paracoagulation. The development of ChSI is closely associated with programmed hemodialysis in ESRD, as well as with the systemic autoimmune process. Consideration of ESRD pathogenesis from the standpoint of the theory of general pathological processes opens up the scope not only for particular but also for universal approaches to conducting pathogenetic therapies and diagnosing and predicting systemic complications in severe nephropathies.<\/jats:p>","DOI":"10.3390\/ijms222111453","type":"journal-article","created":{"date-parts":[[2021,10,24]],"date-time":"2021-10-24T22:06:16Z","timestamp":1635113176000},"page":"11453","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":84,"title":["The Pathogenesis of End-Stage Renal Disease from the Standpoint of the Theory of General Pathological Processes of Inflammation"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7145-2376","authenticated-orcid":false,"given":"Evgenii","family":"Gusev","sequence":"first","affiliation":[{"name":"Institute of Immunology and Physiology, Ural Branch of the Russian Academy of Sciences, 620049 Ekaterinburg, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliya","family":"Solomatina","sequence":"additional","affiliation":[{"name":"Institute of Immunology and Physiology, Ural Branch of the Russian Academy of Sciences, 620049 Ekaterinburg, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3266-0954","authenticated-orcid":false,"given":"Yulia","family":"Zhuravleva","sequence":"additional","affiliation":[{"name":"Institute of Immunology and Physiology, Ural Branch of the Russian Academy of Sciences, 620049 Ekaterinburg, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3101-9655","authenticated-orcid":false,"given":"Alexey","family":"Sarapultsev","sequence":"additional","affiliation":[{"name":"Institute of Immunology and Physiology, Ural Branch of the Russian Academy of Sciences, 620049 Ekaterinburg, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1590\/1806-9282.66.s1.3","article-title":"Chronic Kidney Disease","volume":"66","author":"Ammirati","year":"2020","journal-title":"Rev. Assoc. Med. Bras."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.trsl.2020.09.001","article-title":"Challenges of Reducing Protein-Bound Uremic Toxin Levels in Chronic Kidney Disease and End Stage Renal Disease","volume":"229","author":"Faria","year":"2021","journal-title":"Transl. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1097\/TP.0000000000002366","article-title":"A 2018 Reference Guide to the Banff Classification of Renal Allograft Pathology","volume":"102","author":"Roufosse","year":"2018","journal-title":"Transplantation"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"A6","DOI":"10.1053\/j.ajkd.2019.09.003","article-title":"US Renal Data System 2019 Annual Data Report: Epidemiology of Kidney Disease in the United States","volume":"75","author":"Saran","year":"2020","journal-title":"Am. J. Kidney Dis."},{"key":"ref_5","unstructured":"Benjamin, O., and Lappin, S.L. (2021). End-Stage Renal Disease. StatPearls [Internet], StatPearls Publishing."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/eci.12559","article-title":"High Cut-off Dialysis in Chronic Haemodialysis Patients","volume":"45","author":"Girndt","year":"2015","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_7","first-page":"8458","article-title":"Autonomic Dysfunction in Kidney Diseases","volume":"24","author":"Lai","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.pop.2020.08.002","article-title":"Nephrotic Syndrome","volume":"47","author":"Politano","year":"2020","journal-title":"Prim. Care"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2147\/CLEP.S242264","article-title":"Incidence Rate of Advanced Chronic Kidney Disease Among Privately Insured Adults with Neurodevelopmental Disabilities","volume":"12","author":"Whitney","year":"2020","journal-title":"Clin. Epidemiol."},{"key":"ref_10","unstructured":"Zemaitis, M.R., Foris, L.A., Katta, S., and Bashir, K. (2021). Uremia. StatPearls [Internet], StatPearls Publishing."},{"key":"ref_11","unstructured":"Murdeshwar, H.N., and Anjum, F. (2021). Hemodialysis. StatPearls [Internet], StatPearls Publishing."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/nep.12561","article-title":"Mortality in Hospitalized Chronic Kidney Disease Patients Starting Unplanned Urgent Haemodialysis","volume":"21","author":"Panocchia","year":"2016","journal-title":"Nephrology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"322","DOI":"10.4239\/wjd.v11.i8.322","article-title":"Range of Adiposity and Cardiorenal Syndrome","volume":"11","author":"Pazos","year":"2020","journal-title":"World J. Diabetes"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3389\/fmed.2018.00076","article-title":"Glomerular Endothelial Cell Stress and Cross-Talk with Podocytes in Early [Corrected] Diabetic Kidney Disease","volume":"5","author":"Daehn","year":"2018","journal-title":"Front. Med."},{"key":"ref_15","unstructured":"Finnigan, N.A., and Leslie, S.W. (2021). Polycystic Kidney Disease in Adults. StatPearls [Internet], StatPearls Publishing."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"v39","DOI":"10.1093\/rheumatology\/keaa381","article-title":"Lupus Nephritis: Clinical Presentations and Outcomes in the 21st Century","volume":"59","author":"Gasparotto","year":"2020","journal-title":"Rheumatology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4103\/npmj.npmj_109_19","article-title":"Clinical, Morphologic and Histological Features of Chronic Pyelonephritis: An 8-Year Review","volume":"27","author":"Ademola","year":"2020","journal-title":"Niger. Postgrad. Med. J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41572-019-0109-9","article-title":"Autosomal Dominant Tubulointerstitial Kidney Disease","volume":"5","author":"Devuyst","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"545","DOI":"10.4103\/1319-2442.206441","article-title":"Chronic Renal Failure: An Autopsy Study","volume":"28","author":"Padmanabhan","year":"2017","journal-title":"Saudi J. Kidney Dis. Transplant."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"R298","DOI":"10.1186\/cc13167","article-title":"End-Stage Renal Disease and Outcome in a Surgical Intensive Care Unit","volume":"17","author":"Apel","year":"2013","journal-title":"Crit. Care"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/j.ajkd.2018.03.025","article-title":"GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD","volume":"72","author":"Tuegel","year":"2018","journal-title":"Am. J. Kidney Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.mayocp.2018.05.003","article-title":"End-Stage Renal Disease Risk in Different Glomerulonephropathies","volume":"93","author":"Onuigbo","year":"2018","journal-title":"Mayo Clin. Proc."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.mayocp.2017.10.021","article-title":"End-Stage Renal Disease and Mortality Outcomes Across Different Glomerulonephropathies in a Large Diverse US Population","volume":"93","author":"Sim","year":"2018","journal-title":"Mayo Clin. Proc."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"731","DOI":"10.4103\/0366-6999.226906","article-title":"The Spectrum of Biopsy-Proven Glomerular Disease in China: A Systematic Review","volume":"131","author":"Yang","year":"2018","journal-title":"Chin. Med. J."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Lin, J., Jiang, Z., Liu, C., Zhou, D., Song, J., Liao, Y., and Chen, J. (2020). Emerging Roles of Long Non-Coding RNAs in Renal Fibrosis. Life, 10.","DOI":"10.3390\/life10080131"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1038\/s41598-020-65352-y","article-title":"Inhibition of MTOR Delayed but Could Not Prevent Experimental Collapsing Focal Segmental Glomerulosclerosis","volume":"10","author":"Miesen","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.kint.2020.02.041","article-title":"The Role of Renal Hypoxia in the Pathogenesis of Diabetic Kidney Disease: A Promising Target for Newer Renoprotective Agents Including SGLT2 Inhibitors?","volume":"98","author":"Hesp","year":"2020","journal-title":"Kidney Int."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Hamza, E., Metzinger, L., and Metzinger-Le Meuth, V. (2020). Uremic Toxins Affect Erythropoiesis during the Course of Chronic Kidney Disease: A Review. Cells, 9.","DOI":"10.3390\/cells9092039"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/s41440-020-0491-4","article-title":"Recent Advances in the Management of Secondary Hypertension: Chronic Kidney Disease","volume":"43","author":"Masuda","year":"2020","journal-title":"Hypertens. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s00059-019-04884-0","article-title":"Cardiovascular Disease in Patients with Chronic Kidney Disease","volume":"45","author":"Saritas","year":"2020","journal-title":"Herz"},{"key":"ref_31","first-page":"CD011122","article-title":"Early versus Delayed Erythropoietin for the Anaemia of End-Stage Kidney Disease","volume":"2015","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1182\/blood-2018-06-856500","article-title":"Anemia of Inflammation","volume":"133","author":"Weiss","year":"2019","journal-title":"Blood"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Cohen, G. (2020). Immune Dysfunction in Uremia 2020. Toxins, 12.","DOI":"10.3390\/toxins12070439"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Betjes, M.G. (2020). Uremia-Associated Ageing of the Thymus and Adaptive Immune Responses. Toxins, 12.","DOI":"10.3390\/toxins12040224"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12979-020-00200-1","article-title":"Emergence of T Cell Immunosenescence in Diabetic Chronic Kidney Disease","volume":"17","author":"Chiu","year":"2020","journal-title":"Immun. Ageing"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Ebert, T., Pawelzik, S.-C., Witasp, A., Arefin, S., Hobson, S., Kublickiene, K., Shiels, P.G., B\u00e4ck, M., and Stenvinkel, P. (2020). Inflammation and Premature Ageing in Chronic Kidney Disease. Toxins, 12.","DOI":"10.3390\/toxins12040227"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1042\/CS20200279","article-title":"Microvascular Disease in Chronic Kidney Disease: The Base of the Iceberg in Cardiovascular Comorbidity","volume":"134","author":"Querfeld","year":"2020","journal-title":"Clin. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cca.2020.03.008","article-title":"The Endothelin System as Target for Therapeutic Interventions in Cardiovascular and Renal Disease","volume":"506","author":"Eroglu","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e014840","DOI":"10.1161\/JAHA.119.014840","article-title":"Statins and All-Cause Mortality in Patients Undergoing Hemodialysis","volume":"9","author":"Jung","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s40620-020-00842-w","article-title":"Renal Dysfunction in Cardiovascular Diseases and Its Consequences","volume":"34","author":"Deferrari","year":"2021","journal-title":"J. Nephrol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"31","DOI":"10.31083\/j.rcm.2020.01.24","article-title":"Management of Heart Failure in Patients with End-Stage Kidney Disease on Maintenance Dialysis: A Practical Guide","volume":"21","author":"Joseph","year":"2020","journal-title":"Rev. Cardiovasc. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"76","DOI":"10.14740\/cr955","article-title":"An Update on the Pathophysiology and Treatment of Cardiorenal Syndrome","volume":"11","author":"Raina","year":"2020","journal-title":"Cardiol. Res"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10741-011-9291-x","article-title":"The Cardiorenal Syndrome in Heart Failure: Cardiac? Renal? Syndrome?","volume":"17","author":"Triposkiadis","year":"2012","journal-title":"Heart Fail. Rev."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1590\/1516-3180.2017.0179150817","article-title":"A Study of Pulmonary Function in End-Stage Renal Disease Patients on Hemodialysis: A Cross-Sectional Study","volume":"135","author":"Sharma","year":"2017","journal-title":"Sao Paulo Med. J."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.12659\/MSM.897480","article-title":"Pulmonary Function in Patients with End-Stage Renal Disease: Effects of Hemodialysis and Fluid Overload","volume":"22","author":"Yildirim","year":"2016","journal-title":"Med. Sci. Monit."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s11011-013-9438-7","article-title":"Predominant Gray Matter Volume Loss in Patients with End-Stage Renal Disease: A Voxel-Based Morphometry Study","volume":"28","author":"Zhang","year":"2013","journal-title":"Metab. Brain Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.jfma.2019.01.011","article-title":"Cognitive Impairment in Patients with End-Stage Renal Disease: Accelerated Brain Aging?","volume":"118","author":"Chiu","year":"2019","journal-title":"J. Formos. Med. Assoc."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cgh.2017.05.041","article-title":"New Developments in Hepatorenal Syndrome","volume":"16","author":"Mindikoglu","year":"2018","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"m2687","DOI":"10.1136\/bmj.m2687","article-title":"Hepatorenal Syndrome: Pathophysiology, Diagnosis, and Management","volume":"370","author":"Simonetto","year":"2020","journal-title":"BMJ"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"774","DOI":"10.2215\/CJN.12451018","article-title":"Hepatorenal Syndrome","volume":"14","author":"Francoz","year":"2019","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1631\/jzus.B1900490","article-title":"Roles of Pattern Recognition Receptors in Diabetic Nephropathy","volume":"21","author":"Zhou","year":"2020","journal-title":"J. Zhejiang Univ.-Sci. B"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2174\/1381612825666190319114641","article-title":"Cellular Stress and General Pathological Processes","volume":"25","author":"Gusev","year":"2019","journal-title":"Curr. Pharm. Des."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s11906-020-01116-3","article-title":"Management of Hyperuricemia in Patients with Chronic Kidney Disease: A Focus on Renal Protection","volume":"22","author":"Kielstein","year":"2020","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11892-017-0841-z","article-title":"Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease","volume":"17","author":"Sabatino","year":"2017","journal-title":"Curr. Diabetes Rep."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2147\/IJNRD.S200297","article-title":"Butyrate Production in Patients with End-Stage Renal Disease","volume":"12","author":"Terpstra","year":"2019","journal-title":"Int. J. Nephrol. Renovasc. Dis."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-981-15-2385-4_7","article-title":"Gut Microbiota and Renal Injury","volume":"1238","author":"Zhang","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"214074","DOI":"10.1155\/2010\/214074","article-title":"Cellular Stress Responses: Cell Survival and Cell Death","volume":"2010","author":"Fulda","year":"2010","journal-title":"Int. J. Cell. Biol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1529\/biophysj.106.090084","article-title":"Mathematical Models of Specificity in Cell Signaling","volume":"92","author":"Bardwell","year":"2007","journal-title":"Biophys. J."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jbior.2015.09.009","article-title":"Reciprocal Regulation of P53 and NF-\u039aB by Diacylglycerol Kinase \u03b6","volume":"60","author":"Tanaka","year":"2016","journal-title":"Adv. Biol. Regul."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1128\/MCB.19.5.3485","article-title":"Transcriptional Cross Talk between NF-\u03baB and P53","volume":"19","author":"Webster","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fcell.2018.00023","article-title":"Microenvironment-Cell Nucleus Relationship in the Context of Oxidative Stress","volume":"6","author":"Chittiboyina","year":"2018","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.cellsig.2013.11.004","article-title":"Macrophage Polarization and Function with Emphasis on the Evolving Roles of Coordinated Regulation of Cellular Signaling Pathways","volume":"26","author":"Zhou","year":"2014","journal-title":"Cell. Signal."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/jcb.25074","article-title":"Regulation of Hypoxia-Inducible Factor-1a by Reactive Oxygen Species: New Developments in an Old Debate","volume":"116","author":"Movafagh","year":"2015","journal-title":"J. Cell. Biochem."},{"key":"ref_64","first-page":"1","article-title":"Inflammation and the Microcirculation","volume":"2","author":"Granger","year":"2010","journal-title":"Colloq. Ser. Integr. Syst. Physiol.: Mol. Funct."},{"key":"ref_65","unstructured":"Majno, G., and Joris, I. (2004). Cells, Tissues, and Disease: Principles of General Pathology, Oxford University Press. [2nd ed.]."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Pietzner, M., Kaul, A., Henning, A.-K., Kastenm\u00fcller, G., Artati, A., Lerch, M.M., Adamski, J., Nauck, M., and Friedrich, N. (2017). Comprehensive Metabolic Profiling of Chronic Low-Grade Inflammation among Generally Healthy Individuals. BMC Med., 15.","DOI":"10.1186\/s12916-017-0974-6"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/mi.2017.19","article-title":"Inflammasomes and Intestinal Inflammation","volume":"10","author":"Zmora","year":"2017","journal-title":"Mucosal. Immunol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1152\/physrev.90100.2007","article-title":"Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6","volume":"88","author":"Pedersen","year":"2008","journal-title":"Physiol. Rev."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.2174\/1381612824666180327165604","article-title":"Signaling Pathways in Inflammation and Anti-Inflammatory Therapies","volume":"24","author":"Yeung","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.4049\/jimmunol.1601515","article-title":"Akt Signaling Pathway in Macrophage Activation and M1\/M2 Polarization","volume":"198","author":"Vergadi","year":"2017","journal-title":"J. Immunol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"E29","DOI":"10.1152\/ajpendo.90331.2008","article-title":"Emerging Role for AS160\/TBC1D4 and TBC1D1 in the Regulation of GLUT4 Traffic","volume":"295","author":"Sakamoto","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.3389\/fimmu.2020.01249","article-title":"The Role of Endogenous Eicosapentaenoic Acid and Docosahexaenoic Acid-Derived Resolvins in Systemic Sclerosis","volume":"11","author":"Rossi","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature13479","article-title":"Pro-Resolving Lipid Mediators Are Leads for Resolution Physiology","volume":"510","author":"Serhan","year":"2014","journal-title":"Nature"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00394-019-02022-4","article-title":"Intakes of Long-Chain Omega-3 Polyunsaturated Fatty Acids and Non-Fried Fish in Relation to Incidence of Chronic Kidney Disease in Young Adults: A 25-Year Follow-Up","volume":"59","author":"Park","year":"2020","journal-title":"Eur. J. Nutr."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.dsx.2017.08.005","article-title":"Role of Omentin 1 and IL-6 in Type 2 Diabetes Mellitus Patients with Diabetic Nephropathy","volume":"12","author":"Senthilkumar","year":"2018","journal-title":"Diabetes Metab. Syndr."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"7","DOI":"10.15789\/1563-0625-PAP-1893","article-title":"Physiological and pathogenic role of scavenger receptors in humans","volume":"22","author":"Gusev","year":"2020","journal-title":"Med. Immunol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1515\/bmc-2016-0021","article-title":"Advanced Glycation End Products Mediated Cellular and Molecular Events in the Pathology of Diabetic Nephropathy","volume":"7","author":"Chitra","year":"2016","journal-title":"Biomol. Concepts"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1525-1594.2005.29110.x","article-title":"Aberrant Activation of the TNF-Alpha System and Production of Fas and Scavenger Receptors on Monocytes in Patients with End-Stage Renal Disease","volume":"29","author":"Wu","year":"2005","journal-title":"Artif. Organs"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrneph.2017.126","article-title":"CD36 in Chronic Kidney Disease: Novel Insights and Therapeutic Opportunities","volume":"13","author":"Yang","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0018-506X(02)00024-7","article-title":"The Concept of Allostasis in Biology and Biomedicine","volume":"43","author":"McEwen","year":"2003","journal-title":"Horm. Behav."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.mad.2018.07.006","article-title":"Proinflammatory Cytokines and Ageing of the Cardiovascular-Renal System","volume":"175","author":"Smykiewicz","year":"2018","journal-title":"Mech. Ageing Dev."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Hern\u00e1ndez-Saavedra, D., and Stanford, K.I. (2019). The Regulation of Lipokines by Environmental Factors. Nutrients, 11.","DOI":"10.3390\/nu11102422"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/cvr\/cvx093","article-title":"The Microcirculation: A Key Player in Obesity-Associated Cardiovascular Disease","volume":"113","author":"Sorop","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/MAJ.0000000000000511","article-title":"Mechanisms of Cachexia in Chronic Disease States","volume":"350","author":"Yoshida","year":"2015","journal-title":"Am. J. Med. Sci."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"15018","DOI":"10.1038\/nrdp.2015.18","article-title":"Diabetic Kidney Disease","volume":"1","author":"Thomas","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_86","first-page":"6683","article-title":"HMGB1 Is Activated in Type 2 Diabetes Mellitus Patients and in Mesangial Cells in Response to High Glucose","volume":"8","author":"Chen","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.3390\/jcm4051010","article-title":"Biomarkers of Renal Disease and Progression in Patients with Diabetes","volume":"4","author":"Hojs","year":"2015","journal-title":"J. Clin. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1182\/asheducation-2015.1.14","article-title":"Understanding Anemia of Chronic Disease","volume":"2015","author":"Fraenkel","year":"2015","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.dsx.2018.04.035","article-title":"Evaluation of Serum Adiponectin Levels in Diabetic Nephropathy","volume":"13","author":"Alnaggar","year":"2019","journal-title":"Diabetes Metab. Syndr."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3109\/1354750X.2015.1118536","article-title":"Circulating Resistin Is a Significant Predictor of Mortality Independently from Cardiovascular Comorbidities in Elderly, Non-Diabetic Subjects with Chronic Kidney Disease","volume":"21","author":"Marouga","year":"2016","journal-title":"Biomarkers"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1007\/s13300-020-00888-w","article-title":"Insights into the Role of Renal Biopsy in Patients with T2DM: A Literature Review of Global Renal Biopsy Results","volume":"11","author":"Tong","year":"2020","journal-title":"Diabetes Ther."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1042\/CS20160636","article-title":"Diabetic Nephropathy\u2014Is this an immune disorder?","volume":"131","author":"Tesch","year":"2017","journal-title":"Clin. Sci."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1042\/CS20070411","article-title":"Heat-Shock Protein Gene Polymorphisms and the Risk of Nephropathy in Patients with Type 2 Diabetes","volume":"116","author":"Buraczynska","year":"2009","journal-title":"Clin. Sci."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"e000726","DOI":"10.1136\/bmjdrc-2019-000726","article-title":"Retinopathy Progression and the Risk of End-Stage Kidney Disease: Results from a Longitudinal Japanese Cohort of 232 Patients with Type 2 Diabetes and Biopsy-Proven Diabetic Kidney Disease","volume":"7","author":"Yamanouchi","year":"2019","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/1753-0407.13077","article-title":"Interstitial Eosinophilic Infiltration in Diabetic Nephropathy Is Indicative of Poor Prognosis, with No Therapy Benefit from Steroid","volume":"12","author":"Wu","year":"2020","journal-title":"J. Diabetes"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/978-981-13-8871-2_4","article-title":"A Glimpse of the Mechanisms Related to Renal Fibrosis in Diabetic Nephropathy","volume":"1165","author":"Zeng","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"424","DOI":"10.2174\/1566523218666180214100351","article-title":"Role of Immune Cells in Diabetic Kidney Disease","volume":"17","author":"Yang","year":"2017","journal-title":"Curr. Gene Ther."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2923072","DOI":"10.1155\/2019\/2923072","article-title":"Roles of Inflammasomes in Inflammatory Kidney Diseases","volume":"2019","author":"Fan","year":"2019","journal-title":"Mediat. Inflamm."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Duni, A., Liakopoulos, V., Roumeliotis, S., Peschos, D., and Dounousi, E. (2019). Oxidative Stress in the Pathogenesis and Evolution of Chronic Kidney Disease: Untangling Ariadne\u2019s Thread. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20153711"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/JLB.MR1217-489R","article-title":"The Role of IL-20 in Chronic Kidney Disease and Diabetic Nephropathy: Pathogenic and Therapeutic Implications","volume":"104","author":"Chang","year":"2018","journal-title":"J. Leukoc. Biol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1111\/bph.15013","article-title":"IL-11 in Cardiac and Renal Fibrosis: Late to the Party but a Central Player","volume":"177","author":"Corden","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000490396","article-title":"CXCL12 in Patients with Chronic Kidney Disease and Healthy Controls: Relationships to Ambulatory 24-Hour Blood Pressure and Echocardiographic Measures","volume":"8","author":"Pilecki","year":"2018","journal-title":"Cardiorenal Med."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/jcmm.13060","article-title":"Signalling Pathways Involved in Hypoxia-Induced Renal Fibrosis","volume":"21","author":"Liu","year":"2017","journal-title":"J. Cell. Mol. Med."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrneph.2014.114","article-title":"Inflammatory Processes in Renal Fibrosis","volume":"10","author":"Meng","year":"2014","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1369\/0022155419849386","article-title":"Novel Targets for Therapy of Renal Fibrosis","volume":"67","author":"Prakoura","year":"2019","journal-title":"J. Histochem. Cytochem."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/MNH.0b013e328351a391","article-title":"Fibroblast Growth Factor 23 and Adverse Clinical Outcomes in Chronic Kidney Disease","volume":"21","author":"Isakova","year":"2012","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.atherosclerosis.2009.05.013","article-title":"Serum Intact FGF23 Associate with Left Ventricular Mass, Hypertrophy and Geometry in an Elderly Population","volume":"207","author":"Mirza","year":"2009","journal-title":"Atherosclerosis"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00467-003-1323-x","article-title":"Increased Expression of Mast Cells in Reflux Nephropathy","volume":"19","author":"Solari","year":"2004","journal-title":"Pediatric Nephrol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/modpathol.3880184","article-title":"Increased Density of Interstitial Mast Cells in Amyloid A Renal Amyloidosis","volume":"13","author":"Jimi","year":"2000","journal-title":"Mod. Pathol."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Li, X. (2015). Role of Inflammation in Polycystic Kidney Disease. Polycystic Kidney Disease, Codon Publications.","DOI":"10.15586\/codon.pkd.2015"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1753-0407.2009.00042.x","article-title":"Metabolic Syndrome and Chronic Kidney Disease","volume":"1","author":"Ruan","year":"2009","journal-title":"J. Diabetes"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000479254","article-title":"End-Stage Renal Disease, Inflammation and Cardiovascular Outcomes","volume":"191","author":"Dai","year":"2017","journal-title":"Contrib. Nephrol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/j.ekir.2020.08.031","article-title":"Dialysis-Induced Cardiovascular and Multiorgan Morbidity","volume":"5","author":"Canaud","year":"2020","journal-title":"Kidney Int. Rep."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/sdi.12694","article-title":"Hemodialysis-induced cardiovascular disease","volume":"31","author":"Ahmadmehrabi","year":"2018","journal-title":"Semin. Dial."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s10047-018-1059-9","article-title":"The Biocompatibility and Bioactivity of Hemodialysis Membranes: Their Impact in End-Stage Renal Disease","volume":"22","author":"Amorim","year":"2019","journal-title":"J. Artif. Organs"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/ndt\/gfx050","article-title":"Uremia Induces Adipose Tissue Inflammation and Muscle Mitochondrial Dysfunction","volume":"32","author":"Lin","year":"2017","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1134\/S2079086419040029","article-title":"Correlation of the Evolution of Immunity and Inflammation in Vertebrates","volume":"9","author":"Gusev","year":"2019","journal-title":"Biol. Bull. Rev."},{"key":"ref_118","unstructured":"Abbas, A.K., Lichtman, A.H., and Pillai, S. (2018). Cellular and Molecular Immunology, Elsevier. [9th ed.]."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"814","DOI":"10.3390\/biology4040814","article-title":"Along the Axis between Type 1 and Type 2 Immunity; Principles Conserved in Evolution from Fish to Mammals","volume":"4","author":"Yamaguchi","year":"2015","journal-title":"Biology"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1126\/science.1178331","article-title":"Development of Monocytes, Macrophages, and Dendritic Cells","volume":"327","author":"Geissmann","year":"2010","journal-title":"Science"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","article-title":"Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines","volume":"41","author":"Murray","year":"2014","journal-title":"Immunity"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/intimm\/dxw006","article-title":"CD4+ T-Cell Subsets in Inflammatory Diseases: Beyond the Th1\/Th2 Paradigm","volume":"28","author":"Hirahara","year":"2016","journal-title":"Int. Immunol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.immuni.2008.11.005","article-title":"Late Developmental Plasticity in the T Helper 17 Lineage","volume":"30","author":"Lee","year":"2009","journal-title":"Immunity"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"925135","DOI":"10.1155\/2012\/925135","article-title":"CD4+T Cells: Differentiation and Functions","volume":"2012","author":"Luckheeram","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"5983","DOI":"10.4049\/jimmunol.1001255","article-title":"An Intrinsic Mechanism Predisposes Foxp3-Expressing Regulatory T Cells to Th2 Conversion in Vivo","volume":"185","author":"Wang","year":"2010","journal-title":"J. Immunol."},{"key":"ref_126","unstructured":"Rose, N., and Mackay, I. (2019). The Autoimmune Diseases, Academic Press. [6th ed.]."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12969-015-0003-2","article-title":"Enthesitis as a Component of Dactylitis in Psoriatic Juvenile Idiopathic Arthritis: Histology of an Established Clinical Entity","volume":"13","author":"Tuttle","year":"2015","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"4204512","DOI":"10.1155\/2019\/4204512","article-title":"Type 2 Inflammatory Responses in Autoimmune Demyelination of the Central Nervous System: Recent Advances","volume":"2019","author":"Costanza","year":"2019","journal-title":"J. Immunol. Res."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s40620-017-0412-z","article-title":"ANCA-Associated Vasculitis with Renal Involvement","volume":"31","author":"Binda","year":"2018","journal-title":"J. Nephrol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"350","DOI":"10.5301\/jn.5000151","article-title":"A Histologic Classification of IgA Nephropathy for Predicting Long-Term Prognosis: Emphasis on End-Stage Renal Disease","volume":"26","author":"Kawamura","year":"2013","journal-title":"J. Nephrol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.molimm.2019.07.017","article-title":"The Role of Complement in IgA Nephropathy","volume":"114","author":"Tortajada","year":"2019","journal-title":"Mol. Immunol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/978-981-13-8871-2_20","article-title":"Complement Activation in Progression of Chronic Kidney Disease","volume":"1165","author":"Chen","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s40620-016-0299-0","article-title":"Markers for the Progression of IgA Nephropathy","volume":"29","author":"Maixnerova","year":"2016","journal-title":"J. Nephrol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.humpath.2016.05.015","article-title":"Glomerular C3d as a Novel Prognostic Marker for Renal Vasculitis","volume":"56","author":"Villacorta","year":"2016","journal-title":"Hum. Pathol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1681\/ASN.2005010078","article-title":"Membranoproliferative Glomerulonephritis Type II (Dense Deposit Disease): An Update","volume":"16","author":"Appel","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fimmu.2018.00071","article-title":"The Complement System in Dialysis: A Forgotten Story?","volume":"9","author":"Poppelaars","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_137","first-page":"32","article-title":"The Role of Th1 and Th17 Cells in Glomerulonephritis","volume":"4","author":"Bagheri","year":"2015","journal-title":"J. Nephropathol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00281-007-0096-x","article-title":"Role of T Cells and Dendritic Cells in Glomerular Immunopathology","volume":"29","author":"Kurts","year":"2007","journal-title":"Semin. Immunopathol."},{"key":"ref_139","first-page":"186","article-title":"T Lymphocytes in IgA Nephropathy","volume":"20","author":"Tang","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.ajpath.2011.05.039","article-title":"Interleukin-17A Promotes Early but Attenuates Established Disease in Crescentic Glomerulonephritis in Mice","volume":"179","author":"Odobasic","year":"2011","journal-title":"Am. J. Pathol."},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Ara\u00fajo, L.S., Torquato, B.G.S., da Silva, C.A., Dos Reis Monteiro, M.L.G., Dos Santos Martins, A.L.M., da Silva, M.V., Dos Reis, M.A., and Machado, J.R. (2020). Renal Expression of Cytokines and Chemokines in Diabetic Nephropathy. BMC Nephrol., 21.","DOI":"10.1186\/s12882-020-01960-0"},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Calle, P., and Hotter, G. (2020). Macrophage Phenotype and Fibrosis in Diabetic Nephropathy. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21082806"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-981-13-8871-2_3","article-title":"Current Opinion for Hypertension in Renal Fibrosis","volume":"1165","author":"Sun","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3389\/fgene.2020.00993","article-title":"MicroRNAs in Podocyte Injury in Diabetic Nephropathy","volume":"11","author":"Ishii","year":"2020","journal-title":"Front. Genet."},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Lass\u00e9n, E., and Daehn, I.S. (2020). Molecular Mechanisms in Early Diabetic Kidney Disease: Glomerular Endothelial Cell Dysfunction. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21249456"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ijbiomac.2020.01.168","article-title":"Cell Junction Proteins: Crossing the Glomerular Filtration Barrier in Diabetic Nephropathy","volume":"148","author":"Eftekhari","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Roumeliotis, S., Mallamaci, F., and Zoccali, C. (2020). Endothelial Dysfunction in Chronic Kidney Disease, from Biology to Clinical Outcomes: A 2020 Update. J. Clin. Med., 9.","DOI":"10.3390\/jcm9082359"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/ndt\/gfm797","article-title":"Analysis of NO-Synthase Expression and Clinical Risk Factors in Human Diabetic Nephropathy","volume":"23","author":"Hohenstein","year":"2008","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_149","first-page":"103","article-title":"Overexpression of Sirt6 Promotes M2 Macrophage Transformation, Alleviating Renal Injury in Diabetic Nephropathy","volume":"55","author":"Ji","year":"2019","journal-title":"Int. J. Oncol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1755-5922.2010.00218.x","article-title":"Relationship between Oxidative Stress and Inflammatory Cytokines in Diabetic Nephropathy","volume":"30","author":"Elmarakby","year":"2012","journal-title":"Cardiovasc. Ther."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.2174\/1381612824666180716163845","article-title":"M1\/M2 Macrophages in Diabetic Nephropathy: Nrf2\/HO-1 as Therapeutic Targets","volume":"24","author":"Landis","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3389\/fcell.2020.00187","article-title":"Transforming Growth Factor-Beta1 in Diabetic Kidney Disease","volume":"8","author":"Zhao","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_153","first-page":"87","article-title":"Lipotoxicity, Nutrient-Sensing Signals, and Autophagy in Diabetic Nephropathy","volume":"3","author":"Kume","year":"2020","journal-title":"JMA J."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/978-981-15-4272-5_36","article-title":"Autophagy and Diabetic Nephropathy","volume":"1207","author":"Cui","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"8023","DOI":"10.1007\/s11033-020-05749-0","article-title":"Mechanism of Progression of Diabetic Kidney Disease Mediated by Podocyte Mitochondrial Injury","volume":"47","author":"Su","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"794","DOI":"10.3389\/fphys.2020.00794","article-title":"The Link Between the Mitochondrial Fatty Acid Oxidation Derangement and Kidney Injury","volume":"11","author":"Console","year":"2020","journal-title":"Front. Physiol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"514738","DOI":"10.1155\/2011\/514738","article-title":"Role of T Cells in Type 2 Diabetic Nephropathy","volume":"2011","author":"Wu","year":"2011","journal-title":"Exp. Diabetes Res."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/B978-0-12-394317-0.00014-5","article-title":"Cytokines in Diabetic Nephropathy","volume":"56","author":"Wu","year":"2012","journal-title":"Adv. Clin. Chem."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.humimm.2014.02.007","article-title":"The Alteration of Th1\/Th2\/Th17\/Treg Paradigm in Patients with Type 2 Diabetes Mellitus: Relationship with Diabetic Nephropathy","volume":"75","author":"Zhang","year":"2014","journal-title":"Hum. Immunol."},{"key":"ref_160","unstructured":"Hassanein, M., and Augustine, J.J. (2021). Chronic Kidney Transplant Rejection. StatPearls [Internet], StatPearls Publishing. Available online: https:\/\/www.statpearls.com\/articlelibrary\/viewarticle\/19539\/."},{"key":"ref_161","first-page":"82","article-title":"Systemic Inflammation in Chronic Renal Allograft Dysfunction","volume":"13","author":"Gusev","year":"2011","journal-title":"Nephrol. Dyalysis"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.3389\/fimmu.2019.01630","article-title":"End-Stage Renal Disease-Associated Gut Bacterial Translocation: Evolution and Impact on Chronic Inflammation and Acute Rejection After Renal Transplantation","volume":"10","author":"Carron","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1111\/ajt.15898","article-title":"The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell- and antibody-mediated rejection","volume":"20","author":"Loupy","year":"2020","journal-title":"Am. J. Transplant."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/ckj\/sfaa060","article-title":"Recurrence of Immunoglobulin A Nephropathy after Kidney Transplantation: A Narrative Review of the Incidence, Risk Factors, Pathophysiology and Management of Immunosuppressive Therapy","volume":"13","author":"Infante","year":"2020","journal-title":"Clin. Kidney J."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1053\/j.ajkd.2009.03.021","article-title":"Potential Role of Soluble ST2 Protein in Idiopathic Nephrotic Syndrome Recurrence Following Kidney Transplantation","volume":"54","author":"Bruneau","year":"2009","journal-title":"Am. J. Kidney Dis."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"732","DOI":"10.2215\/CJN.09310819","article-title":"Metabolic Disorders with Kidney Transplant","volume":"15","author":"Cohen","year":"2020","journal-title":"Clin. J. Am. Soc. Nephrol"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1034\/j.1399-0012.16.s8.1.x","article-title":"Mast Cells in Human Allografted Kidney: Correlation with Interstitial Fibrosis","volume":"16","author":"Goto","year":"2002","journal-title":"Clin. Transplant."},{"key":"ref_168","first-page":"e376","article-title":"Chronic Renal Transplant Rejection and Possible Anti-Proliferative Drug Targets","volume":"7","author":"Bhatti","year":"2015","journal-title":"Cureus"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.molimm.2017.05.014","article-title":"Complement in Renal Transplantation: The Road to Translation","volume":"89","author":"Jager","year":"2017","journal-title":"Mol. Immunol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.transproceed.2019.02.008","article-title":"Assessment of Interleukin 2 Cytokine Expression Levels After Renal Transplantation","volume":"51","author":"Karahan","year":"2019","journal-title":"Transplant. Proc."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1111\/ajt.13644","article-title":"HLA Class II Antibody Activation of Endothelial Cells Promotes Th17 and Disrupts Regulatory T Lymphocyte Expansion","volume":"16","author":"Lion","year":"2016","journal-title":"Am. J. Transplant."},{"key":"ref_172","doi-asserted-by":"crossref","unstructured":"Ma, L., Zhang, H., Hu, K., Lv, G., Fu, Y., Ayana, D.A., Zhao, P., and Jiang, Y. (2015). The Imbalance between Tregs, Th17 Cells and Inflammatory Cytokines among Renal Transplant Recipients. BMC Immunol., 16.","DOI":"10.1186\/s12865-015-0118-8"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1111\/ajt.13393","article-title":"Intrarenal B Cell Cytokines Promote Transplant Fibrosis and Tubular Atrophy","volume":"15","author":"Tse","year":"2015","journal-title":"Am. J. Transplant."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1432-2277.2010.01157.x","article-title":"T Helper 1, 2 and 17 Cell Subsets in Renal Transplant Patients with Delayed Graft Function","volume":"24","author":"Loverre","year":"2011","journal-title":"Transpl. Int."},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Zotova, N.V., Chereshnev, V.A., and Gusev, E.Y. (2016). Systemic Inflammation: Methodological Approaches to Identification of the Common Pathological Process. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0155138"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4149\/gpb_2019043","article-title":"Integral Estimation of Systemic Inflammatory Response under Sepsis","volume":"39","author":"Zotova","year":"2020","journal-title":"Gen Physiol Biophys"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"154729","DOI":"10.1016\/j.cyto.2019.05.016","article-title":"Endothelial Injury Is Closely Related to Osteopontin and TNF Receptor-Mediated Inflammation in End-Stage Renal Disease","volume":"121","author":"Batko","year":"2019","journal-title":"Cytokine"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s11255-019-02167-5","article-title":"Association of Serum IL-18 with Protein-Energy Wasting in End-Stage Renal Disease Patients on Haemodialysis","volume":"51","author":"Bi","year":"2019","journal-title":"Int. Urol. Nephrol."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"43520","DOI":"10.1038\/srep43520","article-title":"Circulating TNF Receptors 1 and 2 Predict Mortality in Patients with End-Stage Renal Disease Undergoing Dialysis","volume":"7","author":"Gohda","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"583702","DOI":"10.3389\/fimmu.2020.583702","article-title":"Kidney Failure Associates with T Cell Exhaustion and Imbalanced Follicular Helper T Cells","volume":"11","author":"Hartzell","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000447434","article-title":"Markers of Inflammation and Oxidative Stress in the Development and Progression of Renal Disease in Diabetic Patients","volume":"133","author":"Hojs","year":"2016","journal-title":"Nephron"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/ncpneph0273","article-title":"Mechanisms of Disease: Cytokine and Adipokine Signaling in Uremic Cachexia","volume":"2","author":"Mak","year":"2006","journal-title":"Nat. Clin. Pract. Nephrol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1080\/0886022X.2016.1193874","article-title":"Cytokines, Adipocytokines and Inflammatory Markers in Patients on Continuous Ambulatory Peritoneal Dialysis and Hemodialysis","volume":"38","author":"Oncel","year":"2016","journal-title":"Ren. Fail."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1007\/s11255-015-1114-x","article-title":"The Association of High SCD163\/STWEAK Ratio with Cardiovascular Disease in Hemodialysis Patients","volume":"47","author":"Rusu","year":"2015","journal-title":"Int. Urol. Nephrol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"e004911","DOI":"10.1161\/JAHA.116.004911","article-title":"Prognostic Significance of Interleukin-34 (IL-34) in Patients with Chronic Heart Failure with or Without Renal Insufficiency","volume":"6","author":"Tao","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"ref_186","first-page":"44","article-title":"Elevated Plasma Cyclophillin A in Hemodialysis and Peritoneal Dialysis Patients: A Novel Link to Systemic Inflammation","volume":"11","author":"Jin","year":"2017","journal-title":"Iran. J. Kidney Dis."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.cca.2020.07.041","article-title":"Endocan: A Novel Biomarker for Risk Stratification, Prognosis and Therapeutic Monitoring in Human Cardiovascular and Renal Diseases","volume":"509","author":"Bessa","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/ajh\/hpw208","article-title":"Levels of Angiopoietin-Like-2 Are Positively Associated with Aortic Stiffness and Mortality After Kidney Transplantation","volume":"30","author":"Desjardins","year":"2017","journal-title":"Am. J. Hypertens."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"586","DOI":"10.15537\/smj.2018.6.22024","article-title":"Vascular Endothelial Growth Factor and Soluble Vascular Endothelial Growth Factor Receptor-1 in Patients with End-Stage Renal Disease. Associations with Laboratory Findings, Comorbidities, and Medications","volume":"39","author":"Erturk","year":"2018","journal-title":"Saudi Med. J."},{"key":"ref_190","first-page":"248","article-title":"Systemic Inflammatory Reaction in ESRD Patients","volume":"10","author":"Gusev","year":"2008","journal-title":"Nephrol. Dial."},{"key":"ref_191","first-page":"123","article-title":"Comparative Analysis of Markers of Systemic Inflammatory Reaction in End-Stage Renal Disease (ESRD)Patients","volume":"11","author":"Gusev","year":"2009","journal-title":"Nephrol. Dial."},{"key":"ref_192","unstructured":"Solomatina, L.V. (2012). The Role of Chronic Systemic Inflammation in the Pathogenesis of End-Stage Renal Failure in Patients Receiving Programmed Hemodialysis Replacement Therapy. [Ph.D. Thesis, Institute of Immunology and Physiology of Ural Branch of the Russian Academy of Science]. (In Russian)."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1042\/CS20200766","article-title":"Potential Role of Extracellular Vesicles in the Pathophysiology of Glomerular Diseases","volume":"134","author":"Li","year":"2020","journal-title":"Clin. Sci."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"F844","DOI":"10.1152\/ajprenal.00429.2016","article-title":"Extracellular Vesicles in Diagnosis and Therapy of Kidney Diseases","volume":"311","author":"Zhang","year":"2016","journal-title":"Am. J. Physiol.-Ren. Physiol."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/ndt\/gft209","article-title":"Haemostasis in Chronic Kidney Disease","volume":"29","author":"Lutz","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/clinchem\/44.5.930","article-title":"Cardiac Troponin T in Patients with End-Stage Renal Disease: Absence of Expression in Truncal Skeletal Muscle","volume":"44","author":"Haller","year":"1998","journal-title":"Clin. Chem."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S1665-2681(19)31953-2","article-title":"End-Stage Renal Disease and Hepatitis C Infection: Comparison of Alanine Aminotransferase Levels and Liver Histology in Patients with and without Renal Damage","volume":"6","author":"Contreras","year":"2007","journal-title":"Ann. Hepatol."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1358\/dot.2016.52.9.2545017","article-title":"Cachexia","volume":"52","author":"Graul","year":"2016","journal-title":"Drugs Today"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1007\/s40620-020-00840-y","article-title":"Sarcopenia in Chronic Kidney Disease: What Have We Learned so Far?","volume":"34","author":"Sabatino","year":"2021","journal-title":"J. Nephrol."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1007\/s00417-018-4137-z","article-title":"Assessment of Ocular Microcirculation in Patients with End-Stage Kidney Disease","volume":"256","author":"Arimura","year":"2018","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/MCA.0000000000000727","article-title":"End-Stage Renal Failure Is Associated with Impaired Coronary Microvascular Function","volume":"30","author":"Nelson","year":"2019","journal-title":"Coron. Artery Dis."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1053\/j.jrn.2017.04.012","article-title":"Skin Blood Flow and Vascular Endothelium Function in Uremia","volume":"27","author":"Smogorzewski","year":"2017","journal-title":"J. Ren. Nutr."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1681\/ASN.2017020157","article-title":"Assessing Microvascular Function in Humans from a Chronic Disease Perspective","volume":"28","author":"Houben","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000380902","article-title":"Haemodialysis Impairs the Human Microcirculation Independent from Macrohemodynamic Parameters","volume":"40","author":"Meinders","year":"2015","journal-title":"Blood Purif."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/eci.12784","article-title":"An Observational Study of Microcirculation in Dialysis Patients and Kidney Transplant Recipients","volume":"47","author":"Yeh","year":"2017","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_206","first-page":"739","article-title":"Comparison of Clinical and Laboratory Parameters in Patients with End-Stage Renal Failure in the Outcome of Chronic Glomerulonephritis and Patients with End-Stage Renal Failure in the Outcome of Other Diseases","volume":"69","author":"Popova","year":"2016","journal-title":"Wiad Lek."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cca.2009.11.022","article-title":"Hemostatic Changes in Patients with End Stage Renal Disease Undergoing Hemodialysis","volume":"411","author":"Rios","year":"2010","journal-title":"Clin. Chim. Acta"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1055\/s-0030-1248722","article-title":"Disorders of Hemostasis Associated with Chronic Kidney Disease","volume":"36","author":"Jalal","year":"2010","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_209","first-page":"S9","article-title":"Clinical Sequelae of Complement Activation in Hemodialysis","volume":"26","author":"Hakim","year":"1986","journal-title":"Clin. Nephrol."},{"key":"ref_210","first-page":"293","article-title":"Complement Activation and Neutrophil Aggregation Changes during Haemodialysis","volume":"13","author":"Kubatiev","year":"1993","journal-title":"Int. J. Clin. Pharmacol. Res."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.anai.2016.03.009","article-title":"Possible Mast Cell Activation Syndrome in a Patient undergoing Long-Term Hemodialysis","volume":"116","author":"Robertson","year":"2016","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"ref_212","first-page":"161","article-title":"Uremic Pruritus in Chronic Hemodialysis Patients","volume":"21","author":"Narita","year":"2008","journal-title":"J. Nephrol."},{"key":"ref_213","first-page":"327","article-title":"Dermal Mast Cell Density and Pruritus in End-Stage Renal Failure","volume":"23","author":"Leong","year":"1994","journal-title":"Ann. Acad. Med. Singap."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"155369","DOI":"10.1016\/j.cyto.2020.155369","article-title":"Elevated Interleukin 31 Serum Levels in Hemodialysis Patients Are Associated with Uremic Pruritus","volume":"138","author":"Oweis","year":"2021","journal-title":"Cytokine"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/jcp.30.10.960","article-title":"Effect of Renal Transplantation on Marrow Mast Cell Hyperplasia of Chronic Renal Failure","volume":"30","author":"Ellis","year":"1977","journal-title":"J. Clin. Pathol."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1610-0387.2005.05706.x","article-title":"Baseline Serum Levels of Mast Cell Tryptase Are Raised in Hemodialysis Patients and Associated with Severity of Pruritus","volume":"3","author":"Dugas","year":"2005","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/j.1525-139X.2011.00921.x","article-title":"Increased Plasma Chymase Concentration and Mast Cell Chymase Expression in Venous Neointimal Lesions of Patients with CKD and ESRD","volume":"24","author":"Wasse","year":"2011","journal-title":"Semin. Dial."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/cvr\/cvx177","article-title":"Interleukin-9 Mediates Chronic Kidney Disease-Dependent Vein Graft Disease: A Role for Mast Cells","volume":"113","author":"Zhang","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nrneph.2017.17","article-title":"Cardiovascular Disease in Haemodialysis: Role of the Intravascular Innate Immune System","volume":"13","author":"Ekdahl","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00005-012-0191-0","article-title":"Aberrant Function and Differentiation of Monocytes in End Stage Renal Disease","volume":"60","author":"Nowak","year":"2012","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.7150\/ijbs.26111","article-title":"Neutrophil Elastase Inhibitors and Chronic Kidney Disease","volume":"14","year":"2018","journal-title":"Int. J. Biol. Sci."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"108263","DOI":"10.1016\/j.clim.2019.108263","article-title":"Prognostic Role of Circulating Neutrophil Extracellular Traps Levels for Long-Term Mortality in New End-Stage Renal Disease Patients","volume":"210","author":"Kim","year":"2020","journal-title":"Clin. Immunol."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"21747","DOI":"10.1038\/s41598-020-78742-z","article-title":"Enhanced Neutrophil Apoptosis Accompanying Myeloperoxidase Release during Hemodialysis","volume":"10","author":"Fukushi","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"8415179","DOI":"10.1155\/2017\/8415179","article-title":"Increased Neutrophil Extracellular Trap Formation in Uremia Is Associated with Chronic Inflammation and Prevalent Coronary Artery Disease","volume":"2017","author":"Kim","year":"2017","journal-title":"J. Immunol. Res."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000183108","article-title":"Elevated Circulating Levels of Eosinophil Cationic Protein in Uremia as Signs of Abnormal Eosinophil Homeostasis","volume":"36","author":"Grefberg","year":"1984","journal-title":"Nephron"},{"key":"ref_226","first-page":"245","article-title":"Glucocorticoids and Adrenal Androgens in Children with End Stage Renal Disease","volume":"124","author":"Ferraris","year":"1991","journal-title":"Acta Endocrinol."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1530\/EC-12-0058","article-title":"Circadian Rhythm of Salivary Cortisol, Plasma Cortisol, and Plasma ACTH in End-Stage Renal Disease","volume":"2","author":"Raff","year":"2013","journal-title":"Endocr. Connect."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.steroids.2014.03.008","article-title":"Adrenocortical Function in Hypotensive Patients with End Stage Renal Disease","volume":"84","author":"Arregger","year":"2014","journal-title":"Steroids"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3109\/0886022X.2010.528114","article-title":"Misdiagnosis of Addison\u2019s Disease in a Patient with End-Stage Renal Disease","volume":"33","author":"Kocyigit","year":"2011","journal-title":"Ren. Fail."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"131","DOI":"10.15789\/1563-0625-2009-2-3-131-140","article-title":"Progression Variants of Chronic Systemic Inflammation","volume":"11","author":"Gusev","year":"2009","journal-title":"Med. Immunol."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.clim.2016.11.019","article-title":"Prognostic Significance of Repeat Biopsy in Lupus Nephritis: Histopathologic Worsening and a Short Time between Biopsies Is Associated with Significantly Increased Risk for End Stage Renal Disease and Death","volume":"185","author":"Arriens","year":"2017","journal-title":"Clin. Immunol."},{"key":"ref_232","doi-asserted-by":"crossref","unstructured":"Gusev, E., Sarapultsev, A., Hu, D., and Chereshnev, V. (2021). Problems of Pathogenesis and Pathogenetic Therapy of COVID-19 from the Perspective of the General Theory of Pathological Systems (General Pathological Processes). Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22147582"},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12933-021-01343-1","article-title":"Efficacy and durability of multifactorial intervention on mortality and MACEs: A randomized clinical trial in type-2 diabetic kidney disease","volume":"20","author":"Sasso","year":"2021","journal-title":"Cardiovasc. Diabetol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/21\/11453\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:22:11Z","timestamp":1760167331000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/21\/11453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,23]]},"references-count":233,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["ijms222111453"],"URL":"https:\/\/doi.org\/10.3390\/ijms222111453","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,23]]}}}